Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dilapan Versus Prostaglandin E1 in Induction of Midtrimester Abortion

NCT05147857 is registered in ClinicalTrials.gov with Ain Shams Maternity Hospital as lead sponsor.

NCT NCT05147857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05147857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dilapan Versus Prostaglandin E1 in Induction of Midtrimester Abortion
Lead sponsor
Ain Shams Maternity Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2021
Completion date
December 30, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion early